Prognostic role of immune checkpoints mRNA expression in peripheral blood of non-small cell lung cancer patients treated with immune checkpoint inhibitors

C. Papadaki, A. Monastirioti,K. Rounis, D. Kalapanida, G. Kousoulis,K. Michaelidou, E. Vorrias, M. A. Papadaki,D. Mavroudis,S. Agelaki

Annals of Oncology（2022）

引用 0|浏览2

暂无评分

摘要

Although immunotherapy has revolutionized the treatment of patients with non-small cell lung cancer (NSCLC), not all patients respond and reliable prognostic biomarkers are lacking. In the present study we investigated the clinical significance of mRNA expression levels of various immune checkpoints in the circulation of NSCLC patients treated with second line anti-PD1/PD-L1 therapy.

查看译文

关键词

immune checkpoints mrna expression,lung cancer,1072p prognostic role,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要